📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Sanarus

1.1 - Company Overview

Sanarus Logo

Sanarus

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of minimally invasive devices for the diagnosis and treatment of breast tumors, including the Visica treatment system for cryoablation of breast fibroadenomas; the Cassi II rotational core biopsy system, an automated hand held breast biopsy device to secure contiguous biopsy samples; and the ImarC tissue marker system.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Sanarus

Notable Logo

Notable

HQ: United States Website
  • Description: Provider of personalized drug combination testing for cancer patients and a Predictive Medicine Platform (PMP) that predicts patient response to specific therapies to identify responsive patients before treatment. Develops therapeutics, including Presponse Therapeutics and the PLK-1 inhibitor volasertib, with development guided by predictive patient response data.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Notable company profile →
Step Pharma Logo

Step Pharma

HQ: France Website
  • Description: Provider of CTPS1 inhibition therapies, developing STP938, an orally bioavailable CTPS1 inhibitor in clinical development for treating blood cancers and potentially solid tumors. The approach targets the CTPS1 enzyme to inhibit a key step in nucleotide synthesis to treat various cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Step Pharma company profile →
Oncternal Therapeutics Logo

Oncternal Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage oncology treatments, developing a pipeline including ONCT-808, a ROR1-targeting autologous CAR T in Phase 1/2 for relapsed or refractory aggressive B-cell lymphoma; ONCT-534, a dual-action androgen receptor inhibitor for metastatic castration-resistant prostate cancer; and zilovertamab, a ROR1-targeting monoclonal antibody evaluated with other treatments for various cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oncternal Therapeutics company profile →
YM BioSciences Logo

YM BioSciences

HQ: Canada Website
  • Description: Provider of life sciences product development services focused on identifying and advancing a diverse portfolio of cancer-related products at various stages of development, leveraging regulatory and clinical trial expertise and a diversified business model to reduce risk while advancing clinical products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full YM BioSciences company profile →
Biofidelity Logo

Biofidelity

HQ: United Kingdom Website
  • Description: Provider of molecular diagnostic assays and platforms for rapid detection of target DNA sequences and actionable genomic biomarkers, with applications in oncology, prenatal testing, and infectious disease. Products include ASPYRE-Lung for guideline-recommended lung cancer biomarkers with results in days, and ASPYRE, a chemistry platform usable on existing PCR instruments.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biofidelity company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Sanarus

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Sanarus

2.2 - Growth funds investing in similar companies to Sanarus

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Sanarus

4.2 - Public trading comparable groups for Sanarus

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Sanarus

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Sanarus

What does Sanarus do?

Sanarus is a provider of minimally invasive devices for the diagnosis and treatment of breast tumors, including the Visica treatment system for cryoablation of breast fibroadenomas; the Cassi II rotational core biopsy system, an automated hand held breast biopsy device to secure contiguous biopsy samples; and the ImarC tissue marker system.

Who are Sanarus's competitors?

Sanarus's competitors and similar companies include Notable, Step Pharma, Oncternal Therapeutics, YM BioSciences, and Biofidelity.

Where is Sanarus headquartered?

Sanarus is headquartered in United States.

How many employees does Sanarus have?

Sanarus has 1,000 employees 🔒.

When was Sanarus founded?

Sanarus was founded in 2010 🔒.

What sector and industry vertical is Sanarus in?

Sanarus is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Sanarus

Who are the top strategic acquirers in Sanarus's sector and industry

Top strategic M&A buyers and acquirers in Sanarus's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Sanarus?

Top strategic M&A buyers groups and sectors for Sanarus include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Sanarus's sector and industry vertical

Which are the top PE firms investing in Sanarus's sector and industry vertical?

Top PE firms investing in Sanarus's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Sanarus's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Sanarus's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Sanarus's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Sanarus include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Sanarus's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Sanarus?

The key public trading comparables and valuation benchmarks for Sanarus include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Sanarus for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Sanarus with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Sanarus's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Sanarus with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Sanarus's' sector and industry vertical?

Access recent funding rounds and capital raises in Sanarus's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Sanarus